stockrowAmylyx Pharmaceuticals, Inc.
AMLX Healthcare Drug Manufacturers Specialty & Generic
Amylyx Pharmaceuticals, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $87.4 million, down 77.1% from fiscal 2023.
- Revenue
- −100.6%
- EPS
- +15.2%
- Free cash flow
- −24.5%
Quarter to June 2026, against a year earlier
Follow AMLX
Alert me
Amylyx Pharmaceuticals, Inc. (AMLX) Gross margin
Amylyx Pharmaceuticals, Inc.'s gross margin over the twelve months to 31 December 2024 was −42.7%. Over the past ten years it has ranged from −42.7% (fiscal 2024) to 100.0% (fiscal 2021) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 53.5% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2024 | −42.7% | (135.97) |
| FY2023 | 93.3% | 6.78 |
| FY2022 | 86.5% | (13.46) |
| FY2021 | 100.0% | 0.00 |
| FY2020 | 100.0% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Dec 2024 | 100.0% | 194.47 |
| Sep 2024 | −94.5% | (919.59) |
| Jun 2024 | 825.1% | 856.44 |
| Mar 2024 | −31.3% | (122.69) |
| 7 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| LQDA Liquidia Corporation compare | 92.5% |
| SUPN Indivior Pharmaceuticals Inc. compare | 84.9% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| TRLV Trulieve Cannabis Corp. compare | 60.6% |
| PBH Prestige Consumer Healthcare Inc. compare | 52.5% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 44.4% |
| PRGO Perrigo Company plc compare | 32.3% |
| AMLX Amylyx Pharmaceuticals, Inc. | −42.7% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on AMLX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement